Phillygenin Attenuates Carbon Tetrachloride-Induced Liver Fibrosis via Modulating Inflammation and Gut Microbiota
Liver fibrosis is a chronic pathological process that various pathogenic factors lead to abnormal hyperplasia of hepatic connective tissue, and its main feature is the excessive deposition of extracellular matrix. However, there are currently no drugs approved for the treatment of liver fibrosis. Ph...
Main Authors: | Cheng Wang, Cheng Ma, Ke Fu, Li-Hong Gong, Ya-Fang Zhang, Hong-Lin Zhou, Yun-Xia Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.756924/full |
Similar Items
-
Preparation of Phillygenin-Hyaluronic acid composite milk-derived exosomes and its anti-hepatic fibrosis effect
by: Lihong Gong, et al.
Published: (2023-12-01) -
A comprehensive review on pharmacological, toxicity, and pharmacokinetic properties of phillygenin: Current landscape and future perspectives
by: Cheng Wang, et al.
Published: (2023-10-01) -
Synergistic anti-infectious bronchitis virus activity of Phillygenin combined Baicalin by modulating respiratory microbiota and improving metabolic disorders
by: Haipeng Feng, et al.
Published: (2024-02-01) -
Phillygenin inhibited M1 macrophage polarization and reduced hepatic stellate cell activation by inhibiting macrophage exosomal miR-125b-5p
by: Cheng Ma, et al.
Published: (2023-03-01) -
Phillygenin Inhibits Helicobacter pylori by Preventing Biofilm Formation and Inducing ATP Leakage
by: Ru-Jia Li, et al.
Published: (2022-04-01)